256 Newsroom — Uganda's Digital News Infrastructure
Health

Research Shows Melatonin May Help Relieve Certain Types of Chronic Pain - Verywell Health

Share
Research Shows Melatonin May Help Relieve Certain Types of Chronic Pain - Verywell Health
Image · Verywellhealth.com

What the report says

Verywell Health reported that melatonin, widely used as an over-the-counter sleep aid, may also have a role in easing some forms of chronic pain. According to the publisher’s brief description of the research, the findings suggest melatonin could reduce chronic pain in certain cases, although the publicly available text does not identify the study authors, publication date, pain conditions examined, dosage, duration, or the size and design of the research.

Melatonin is a hormone involved in regulating the sleep-wake cycle, and supplements are commonly taken by people seeking help with sleep timing or insomnia symptoms. The Verywell Health item frames the new research as potentially broadening interest in melatonin beyond sleep support, but the available evidence does not establish whether it should be used as a stand-alone pain treatment or which patients might benefit most.

Chronic pain is often difficult to treat and can involve a mix of medication, physical therapy, behavioral approaches, and condition-specific care. If melatonin is found to help specific pain conditions, it could matter because it is inexpensive and widely accessible. However, supplements can still cause side effects, interact with other medicines, and vary in formulation, so medical guidance is important, especially for people with ongoing conditions, pregnancy, seizure disorders, or those taking sedatives, blood thinners, or other regular medications.

Because the full article text was unavailable, this digest should be read as a limited summary of Verywell Health’s reported premise rather than a detailed review of the underlying research.

Read the full report at Verywellhealth.com →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting